Literature DB >> 21632283

Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.

Inger Gustavsson1, Karin Sanner, Monica Lindell, Anders Strand, Matts Olovsson, Ingrid Wikström, Erik Wilander, Ulf Gyllensten.   

Abstract

BACKGROUND: Most procedures for self-sampling of cervical cells are based on liquid-based media for transportation and storage. An alternative is to use a solid support, such as dry filter paper media.
OBJECTIVES: To evaluate if self-sampling of cervicovaginal fluid using a cytobrush (Viba-brush; Rovers Medical Devices B.V., Oss, The Netherlands) and a solid support such as the Whatman Indicating FTA Elute cartridge (GE Healthcare, United Kingdom) can be used for reliable typing of human papillomavirus (HPV), as compared to cervical samples obtained by a physician using a cytobrush and the indicating FTA Elute Micro card and biopsy analysis. STUDY
DESIGN: A total of 50 women with a previous high-risk (HR) HPV positive test were invited to perform self-sampling using the Viba-brush and the FTA cartridge and thereafter a physician obtained a cervical sample using the cytobrush and a FTA card, together with a cervical biopsy for histology and HPV typing. Detection of HR-HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59 was performed using three multiplex real-time polymerase chain reaction (PCR) assays. RESULT: All samples contained sufficient amounts of genomic DNA and the self-samples yielded on average 3.5 times more DNA than those obtained by the physician. All women that were positive for HR-HPV in the biopsy sample also typed positive both by self-sampling and physician-obtained sampling. For women with a histological diagnosis of cervical intraepithelial neoplasia grades 2-3 (CIN 2-3) all three HPV samples showed 100% concordance. A higher number of women were HPV positive by self-sampling than by physician-obtained sampling or by biopsy analysis.
CONCLUSION: The Viba-brush and the FTA cartridge are suitable for self-sampling of vaginal cells and subsequent HR-HPV typing.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21632283     DOI: 10.1016/j.jcv.2011.05.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  15 in total

1.  Evaluation of the FTA carrier device for human papillomavirus testing in developing countries.

Authors:  Paula Gonzalez; Bernal Cortes; Wim Quint; Aimée R Kreimer; Carolina Porras; Ana Cecilia Rodríguez; Silvia Jimenez; Rolando Herrero; Linda Struijk; Allan Hildesheim; Willem Melchers
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

2.  The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.

Authors:  Kimberly L Levinson; Carolina Abuelo; Jorge Salmeron; Eunice Chyung; Jing Zou; Suzanne E Belinson; Guixiang Wang; Carlos Santos Ortiz; Carlos Santiago Vallejos; Jerome L Belinson
Journal:  Gynecol Oncol       Date:  2013-02-04       Impact factor: 5.482

3.  Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens.

Authors:  Yaoyao Guan; Patti E Gravitt; Roslyn Howard; Yolanda J Eby; Shaoming Wang; Belinda Li; Changyan Feng; You-Lin Qiao; Philip E Castle
Journal:  J Virol Methods       Date:  2013-01-29       Impact factor: 2.014

Review 4.  Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.

Authors:  Xaveer Van Ostade; Martin Dom; Wiebren Tjalma; Geert Van Raemdonck
Journal:  Arch Gynecol Obstet       Date:  2017-11-15       Impact factor: 2.344

5.  Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™.

Authors:  Malin Berggrund; Daniel Ekman; Inger Gustavsson; Karin Sundfeldt; Matts Olovsson; Stefan Enroth; Ulf Gyllensten
Journal:  J Circ Biomark       Date:  2016-01-01

6.  Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.

Authors:  Inger Gustavsson; Riina Aarnio; Malin Berggrund; Julia Hedlund-Lindberg; Ann-Sofi Strand; Karin Sanner; Ingrid Wikström; Stefan Enroth; Matts Olovsson; Ulf Gyllensten
Journal:  Br J Cancer       Date:  2018-02-13       Impact factor: 7.640

7.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Authors:  Marc Arbyn; Sara B Smith; Sarah Temin; Farhana Sultana; Philip Castle
Journal:  BMJ       Date:  2018-12-05

8.  Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico-Vaginal Fluid Using LC-MS/MS.

Authors:  Ariadna Lara Gutiérrez; Julia Hedlund Lindberg; Ganna Shevchenko; Inger Gustavsson; Jonas Bergquist; Ulf Gyllensten; Stefan Enroth
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

9.  Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.

Authors:  Shao-Ming Wang; Shang-Ying Hu; Wen Chen; Feng Chen; Fang-Hui Zhao; Wei He; Xin-Ming Ma; Yu-Qing Zhang; Jian Wang; Priya Sivasubramaniam; You-Lin Qiao
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

10.  Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge.

Authors:  Rosa Catarino; Pierre Vassilakos; Aline Bilancioni; Mathieu Vanden Eynde; Ulrike Meyer-Hamme; Pierre-Alain Menoud; Frédéric Guerry; Patrick Petignat
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.